Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,143 | 880 | 1,588 | 2,463 | 0 |
| Marketable Securities | 54 | 54 | 54 | 54 | 0 |
| Receivables | 82 | 135 | 259 | 175 | 0 |
| TOTAL | $1,279 | $1,069 | $1,901 | $2,692 | $0 |
| Non-Current Assets | |||||
| PPE Net | 96 | 100 | 98 | 51 | N/A |
| Other Non-Current Assets | 36 | 42 | 45 | 51 | 0 |
| TOTAL | $132 | $142 | $143 | $102 | $N/A |
| Total Assets | $1,411 | $1,211 | $2,044 | $2,794 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 354 | 153 | 268 | 298 | 0 |
| Accrued Expenses | 269 | 284 | 301 | 305 | 0 |
| TOTAL | $623 | $437 | $569 | $603 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 67 | 84 | 81 | 95 | 0 |
| TOTAL | $67 | $84 | $81 | $95 | $N/A |
| Total Liabilities | $690 | $521 | $650 | $698 | $0 |
| Shareholders' Equity | |||||
| Retained earnings | -13,320 | -12,163 | -11,123 | -10,418 | 0 |
| Other shareholders' equity | 1,885 | 1,575 | 1,247 | 1,264 | 0 |
| TOTAL | $721 | $690 | $1,394 | $2,096 | $0 |
| Total Liabilities And Equity | $1,411 | $1,211 | $2,044 | $2,794 | $0 |